Kosho Murayama
4PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 29, 2025
Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma.Zachary A Cooper, Ying Wang, Philip L Martin
|Nov 07, 2022
Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study.Shunsuke Kondo, Satoru Iwasa, Takafumi Koyama
|Oct 21, 2022
Safety, tolerability, pharmacokinetics and preliminary antitumour activity of an antisense oligonucleotide targeting STAT3 (danvatirsen) as monotherapy and in combination with durvalumab in Japanese patients with advanced solid malignancies: a phase 1 study.Tomohiro Nishina, Tomoko Fujita, Naoto Yoshizuka
|Mar 17, 2021
Safety and antitumor activity of acalabrutinib for relapsed/refractory B-cell malignancies: A Japanese phase I study.Koji Izutsu, Kiyoshi Ando, Daisuke Ennishi
Pageof 1
Frequent Collaborators
2 joint publications
Tomoko Fujita
2 joint publications
Ko Sugibayashi
1 joint publications
Koji Izutsu
1 joint publications
Hirohiko Shibayama
1 joint publications
Kazuhito Yamamoto
1 joint publications
Satoshi Ichikawa
1 joint publications
Koji Kato
1 joint publications
Sakura Iizumi
1 joint publications
Nobuya Hayashi
1 joint publications
Hisashi Kawasumi
